Dr. Lawrence S. Lovitz, MD

Dr. Lovitz practices at HCA Florida Palms West Hospital in Loxahatchee, Florida, part of HCA Healthcare.

Dr. Lovitz's NPI, 1356384150, was assigned on June 13, 2006. Dr. Lovitz graduated from University of Miami, Miller School of Medicine in 1986. Dr. Lovitz holds Florida license ME61334.

Dr. Lovitz's primary practice is HCA Florida Palms West Hospital, at 13001 Southern Blvd, Loxahatchee, FL 33470 in Palm Beach County. The practice phone is (561) 798-3300.

Dr. Lovitz's primary practice is HCA Florida Palms West Hospital in Loxahatchee, Florida, part of HCA Healthcare. Dr. Lovitz is also affiliated with HCA Florida JFK Hospital. The medical group on file is Medical Specialists of the Palm Beaches. Dmand AI also links Dr. Lovitz to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lovitz practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Lovitz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Lovitz is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Lovitz's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and pacemaker or defibrillator implantation among the conditions Dr. Lovitz treats.

CMS data shows 423 Medicare services from Dr. Lovitz across 7 procedure codes in 2024, for 182 Medicare patients. Medicare paid $50,446 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Lovitz in 2024. The largest group is 75 to 84, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lovitz's median patient age at 74, with 36% women.

In 2024, Dr. Lovitz wrote 29 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $86 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Lovitz for performance year 2024, reported as part of a group. Dr. Lovitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 41 procedures of coronary angioplasty and stenting by Dr. Lovitz, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Lovitz, published from 2017 to 2019. Dr. Lovitz's most frequent co-authors are Marcos Agustin Nores, MD, Mohamad Kabach, MD and Mark D. Rothenberg, MD.

CMS Open Payments shows 573 general payments to Dr. Lovitz from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Edwards Lifesciences Corporation paid the most, $60,544.

Dmand AI lists 2 awards for Dr. Lovitz, most recently Gulfstream FL-Palm Beach in 2014.

Dr. Lovitz graduated from University of Miami, Miller School of Medicine in 1986. Dr. Lovitz is a member of ACC.

Dr. Lovitz is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.